Vireo Growth Inc.
Pharmaceutical Preparations · Minneapolis, MN, United States
- PrincipalsAmber Holly ShimpaPresidentJohn MazarakisChief Executive OfficerTyson MacdonaldChief Financial Officerand 2 more
- CompanyVireo Growth Inc.Minneapolis, MN, United States
- Phone line+1 (612) 999-1606General business
Vireo Growth Inc. is an SEC-registered OTC-listed company (ticker VREOF) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 5
Chair & board
Kyle Eugene KingsleyCo-Executive Chairman
Finance
Tyson MacdonaldChief Financial Officer
Legal
Sean Michael ApfelbaumGC and Corporate Secretary
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗John Mazarakis — Chief Executive Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Tyson Macdonald — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Sean Michael Apfelbaum — GC and Corporate Secretary
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Amber Holly Shimpa — President
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Roivant Sciences Ltd.Pharmaceutical Preparations · London1 shared capabilityMereo BioPharma Group plcPharmaceutical Preparations · London1 shared capabilityuniQure N.V.Pharmaceutical Preparations · Amsterdam1 shared capabilityInMed Pharmaceuticals Inc.Pharmaceutical Preparations · Vancouver1 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capabilityLeef Brands Inc.Medicinal Chemicals & Botanical Products · Vancouver1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityTeva Pharmaceutical Industries LtdPharmaceutical Preparations · Tel Aviv1 shared capability